Evidence map›Paper›PMID 34792751›Full record

ArticlePlant molecular biology2022

Editing of the starch branching enzyme gene SBE2 generates high-amylose storage roots in cassava.

Shu Luo, Qiuxiang Ma, Yingying Zhong, Jianling Jing, Zusheng Wei, Wenzhi Zhou, Xinlu Lu, Yinong Tian, Peng Zhang

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Plant molecular biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Manipulation ofPlants (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. CRISPR-Cas9 mediated editing ofFrontiers in genome editing · 2025
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Using the dominant mutation geneMolecular breeding : new strategies in plant improvement · 2022
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Shu LuoNational Key Laboratory of Plant Molecular Genetics, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, 200032, China.
Qiuxiang MaNational Key Laboratory of Plant Molecular Genetics, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, 200032, China. qxma@cemps.ac.cn.ORCID http://orcid.org/0000-0003-4689-5682
Yingying ZhongNational Key Laboratory of Plant Molecular Genetics, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, 200032, China.
Jianling JingNational Key Laboratory of Plant Molecular Genetics, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, 200032, China.
Zusheng WeiGuangxi Subtropical Crops Research Institute, Nanning, 530001, China.
Wenzhi ZhouNational Key Laboratory of Plant Molecular Genetics, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, 200032, China.
Xinlu LuNational Key Laboratory of Plant Molecular Genetics, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, 200032, China.
Yinong TianGuangxi Subtropical Crops Research Institute, Nanning, 530001, China.
Peng ZhangNational Key Laboratory of Plant Molecular Genetics, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, 200032, China. zhangpeng@cemps.ac.cn.ORCID http://orcid.org/0000-0002-4868-1306
Chinese Academy of Sciences · CNGuangxi Subtropical Crops Research Institute · CNCenter for Excellence in Molecular Plant Sciences · CN

Funding

earmarked fund for china agriculture research system CARS-11-shzpnational key research and development program of china 2018YFD1000500national natural science foundation of china 31801417national natural science foundation of china 31871682national natural science foundation of china 32072118natural science foundation of shanghai 17ZR1435200science and technology program of guangxi Guike-AD1850003
6 · The paper itself

Abstract

key messageThe production of high-amylose cassava through CRISPR/Cas9-mediated mutagenesis of the starch branching enzyme gene SBE2 was firstly achieved. High-amylose cassava (Manihot esculenta Crantz) is desirable for starch industrial applications and production of healthier processed food for human consumption. In this study, we report the production of high-amylose cassava through CRISPR/Cas9-mediated mutagenesis of the starch branching enzyme 2 (SBE2). Mutations in two targeted exons of SBE2 were identified in all regenerated plants; these mutations, which included nucleotide insertions, and short or long deletions in the SBE2 gene, were classified into eight mutant lines. Three mutants, M6, M7 and M8, with long fragment deletions in the second exon of SBE2 showed no accumulation of SBE2 protein. After harvest from the field, significantly higher amylose (up to 56% in apparent amylose content) and resistant starch (up to 35%) was observed in these mutants compared with the wild type, leading to darker blue coloration of starch granules after quick iodine staining and altered starch viscosity with a higher pasting temperature and peak time. Further

Indexed as

1,4-alpha-Glucan Branching EnzymeAmyloseClustered Regularly Interspaced Short Palindromic RepeatsGene EditingGene Knockout TechniquesGenes, PlantManihotMutagenesisPlant RootsPlants, Genetically Modified1,4-alpha-Glucan Branching EnzymeAmyloseCassavaGenome editingHigh amyloseStarch branching enzymesStarch property

Identifiers

PMID34792751
OpenAlexW3211692641

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.